GATA-1 inhibitors belong to a specific chemical class of compounds designed to target and inhibit the activity of GATA-1. GATA-1 is a transcription factor that plays a critical role in the development and maturation of red blood cells (erythrocytes) and megakaryocytes, which are the precursors of platelets. It regulates the expression of numerous genes involved in erythroid and megakaryocytic differentiation, including those encoding hemoglobin and platelet-specific proteins.
GATA-1 inhibitors work by specifically targeting the GATA-1 protein, interfering with its ability to bind to DNA and regulate the expression of target genes. By doing so, these inhibitors may modulate the differentiation and maturation of erythrocytes and megakaryocytes, impacting blood cell formation and function. Research into GATA-1 and its inhibitors is ongoing to unravel their precise mechanisms of action and explore their implications in cellular processes. The study of GATA-1 inhibitors represents an intriguing area of research, contributing to a deeper understanding of the intricate mechanisms governing blood cell development and regulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
9-Aminoacridine free base | 90-45-9 | sc-291761A sc-291761 sc-291761B sc-291761C | 250 mg 1 g 5 g 10 g | $32.00 $80.00 $272.00 $501.00 | ||
9-aminoacridine is a synthetic compound that may influence GATA-1 activity. Its specific mechanism of action on GATA-1 is not well-established. | ||||||
Cacodylic acid | 75-60-5 | sc-239453 sc-239453A sc-239453B | 5 g 10 g 25 g | $60.00 $103.00 $204.00 | ||
Cacodylic acid is an organic arsenic compound that may modulate GATA-1 activity. | ||||||